Patent US2801376A successfully refreshed from Google Patents.
Patent US4499105A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4499105A Expired / Lapsed US ⏱️ 0.0 years remaining

Carboxyimidamide derivatives

Assignee: Akzo NV
•
Filing: 1982-12-28
•
Granted: 1985-02-12
•
Expires: 2002-12-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention is dealing with compounds of the formula: ##STR1## and pharmaceutically acceptable salts thereof, in which n and m represent the number 1 or 2, X and Y hydrogen, alkyl (1-4 C), alkoxy (1-4 C), hydroxy, halogen, hydroxymethyl, trifluoromethyl, acyl (1-4 C), acyloxy (1-4 C) or the group NR x R y , in which R x and R y represent hydrogen, alkyl (1-4 C) or a sulphonyl group and R represents the group ##STR2## in which R 1 and R 2 represent hydrogen, alkyl (1-4 C), hydroxy, alkoxy (1-4 C), phenylalkoxy (7-10 C), acyloxy, amino or mono or dialkyl (1-4 C) amino, having potent platelet aggregation inhibiting properties.

Inventors

  • 👤 Harm J. Panneman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 21:30
CPC Classifications
C; C07; C07C; C07C311/00; C07C311/15; C07C311/21; A; A61; A61P; A61P7/00; C07C257/00; C07C257/10; C07C257/16; C07C257/22; C07C259/00; C07C259/12; C07C259/16; C07C2602/00; C07C2602/02; C07C2602/04; C07C2602/10; C07C2602/12; C07C2602/14; C07C2602/24

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 101 words
Carboximidamide derivatives of the general formula: ##STR13## in which n and m represent the value 1 or 2, X and Y hydrogen, alkyl (1-4 C), alkoxy (1-4 C), hydroxy, halogen, hydroxymethyl, trifluoromethyl, acyl (1-4 C), acyloxy (1-4 C) or the group NR x R y , in which R x and R y represent hydrogen, alkyl (1-4 C) or a sulphonyl group and R represents the group: ##STR14## in which R 1 and R 2 represent hydrogen, alkyl (1-4 C), hydroxy, alkoxy (1-4 C), phenylalkoxy (7-10 C), acyloxy, amino or mono- or dialkyl (1-4 C)-amino, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 101 words
Carboximidamide derivatives of the general formula: ##STR13## in which n and m represent the value 1 or 2, X and Y hydrogen, alkyl (1-4 C), alkoxy (1-4 C), hydroxy, halogen, hydroxymethyl, trifluoromethyl, acyl (1-4 C), acyloxy (1-4 C) or the group NR x R y , in which R x and R y represent hydrogen, alkyl (1-4 C) or a sulphonyl group and R represents the group: ##STR14## in which R 1 and R 2 represent hydrogen, alkyl (1-4 C), hydroxy, alkoxy (1-4 C), phenylalkoxy (7-10 C), acyloxy, amino or mono- or dialkyl (1-4 C)-amino, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 47 words
A compound according to claim 1 of the formula: ##STR15## in which X and Y have the meanings indicated in claim 1, m and n have both the value 1 or the value 2 and R 1 is selected from ##STR16## or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 23 words
A compound according to claim 2, in which one of the symbols X and Y or both have a meaning other than hydrogen.
Claim 5
Dependent Claim 21 words
A compound according to claim 3 in which one or both of the symbols X and Y represent an alkoxy group.
Claim 6
Dependent Claim 15 words
Compound in accordance with claim 1 having the formula: ##STR17## or a pharmaceutically-acceptable salt thereof.
Claim 7
Dependent Claim 41 words
A pharmaceutical composition for use as a blood platelet aggregation inhibitor which comprises, as active ingredient, a blood platelet aggregation inhibiting amount of a compound as defined in claim 1, or a pharmaceutically acceptable salt thereof, in a pharmaceutically acceptable carrier.

References Cited (Backward Citations)

NL7310741A Cited
US3978126A Cited
GB1475586A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-02-12 1988-08-13 1989-02-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-02-12 1992-08-13 1993-02-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-02-12 1996-08-13 1997-02-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag